Mini-workshop on “Ophthalmic Drug Innovation, Regulation and Strategies to Reach the Clinical Market” and 3D-NET partners are all set and ready for the final dash of the project after the 3rd Year General Meeting in Nottingham.
The 3D-NET 3rd year general meeting (7th September, 2016) was hosted by (opens in a new window)RenaSci at (opens in a new window)BioCity Nottingham, one of the first Bioscience incubators in Europe. Overall progress of the project was discussed and a revised plan of secondments/research strategy was agreed by all partners to implement during the last year of the project.
In the afternoon, we organised a mini-workshop on “Ophthalmic Drug Innovation, Regulation and Strategies to Reach the Clinical Market”, with open scientific presentations and chaired by Sharon Cheetham (RenaSci) and Sally Hampton (KalVista).
